Zhang, Tian http://orcid.org/0000-0001-8914-3531
George, Daniel J.
Article History
First Online: 5 April 2021
Competing interests
: T.Z. has received research funding (to Duke) from Pfizer, Janssen, Acerta, Abbvie, Novartis, Merrimack, OmniSeq, PGDx, Merck, Mirati, Astellas and Regeneron; has received consulting/speaking fees from Genentech Roche, Exelixis, Genomic Health and Sanofi Aventis; reports serving on an advisory board and/or consulting for AstraZeneca, Bayer, Pfizer, Foundation Medicine, Janssen, Amgen, MJH Associates, Merck, BMS, Pharmacyclics, Seattle Genetics, Calithera and Dendreon; and reports stock ownership and/or employment (spouse) with Capio Biosciences and Archimmune Therapeutics. D.J.G. has received research support (to Duke) from Acerta, Astellas, BMS, Bayer, Calithera, Exelixis, Janssen, Myovant, Pfizer, Novartis and Sanofi Aventis; and consulting fees from Vizuri Health sciences, UroToday, Sanofi, Pfizer, Nektar, Myovant, Modra, Merck, Ipsen, Flatiron, Exelixis, Capio, EMD Serono, BMS, Bayer, AstraZeneca and Astellas.